EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Risk Factors for the Non-timely Diagnosis of Pediatric Type 1 Diabetes

Gabriel A Ellison, Ricardo Medina Peñaranda, Lauren E Figg, Amy Zhang, Kevan C Herold, Korey K Hood, David M Maahs, Osagie Ebekozien, Ananta Addala

Journal of the Endocrine Society · 2026-11-10

DOI: 10.1210/jendso/bvag261 ↗
AbstractBibliografische Angaben

Abstract

Abstract Purpose Non-timely Diagnosis of type 1 diabetes is associated with complications, hinders the therapeutic relationship, and compromises diabetes care delivery. This study aims to identify sociodemographic and clinical risk factors for Non-timely Diagnosis of pediatric type 1 diabetes. Methods We identified youth (6m–21yrs) diagnosed with type 1 diabetes (ADA definition and 1+autoantibody) at Stanford Children’s Hospital from 01/2021-11/2023. Through ICD-10 code review in the STAnford Research Repository followed by chart review of all clinical data, two-person coding team determined if type 1 diabetes was diagnosed Timely or Non-timely. Non-timely was categorized as Unrecognized (symptoms attributed to another diagnosis) or Misclassified (type 2 diabetes diagnosis). Analysis via multivariate logistic regression identified sociodemographic and clinical risk factors for Non-timely Diagnosis. Results Of 197 youth with type 1 diabetes, 49 (25%) were Non-timely Diagnosed (7% Unrecognized, 18% Misclassified). A majority of those who were Unrecognized (78%) and Misclassified (77%) were seen initially in the primary care setting. Acanthosis (aOR=11.25 [3.18,39.80]) was a risk factor for Non-timely Diagnosis, while hospitalization (aOR=0.25 [0.10,0.61]), and female sex (aOR=0.24 [0.09,0.66]) were protective associations. Conclusions A quarter of youth in our study did not receive a timely diagnosis of type 1 diabetes. This study highlights the need for timely and accurate type 1 diabetes diagnosis to reduce delays, establish strong therapeutic relationships, and ensure access to disease modifying immunotherapy. Interventions to combat Non-timely Diagnosis should focus on primary care and diabetes clinic settings. With over 1 in 6 youth Misclassified, autoantibodies are critical to improving diagnostic clarity.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →